Inhibitor Therapeutics (Inhibitor Therapeutics) 6-Month Price Index : 1.06 (As of Jun. 10, 2024)

Competitive Comparison of Inhibitor Therapeutics's 6-Month Price Index

For the Biotechnology subindustry, Inhibitor Therapeutics's 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inhibitor Therapeutics  (OTCPK:INTI) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inhibitor Therapeutics  (OTCPK:INTI) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.

Inhibitor Therapeutics 6-Month Price Index Related Terms

Thank you for viewing the detailed overview of Inhibitor Therapeutics's 6-Month Price Index provided by GuruFocus.com. Please click on the following links to see related term pages.

Inhibitor Therapeutics (Inhibitor Therapeutics) Business Description